Nurse Practitioner, Acute Care · Boston, MA
NPI
1730301060
Since 2007
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
Massachusetts General Hospital, Ellison 14
Boston, MA, 02114
Phone (617) 726-6349
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
657 services
Medicare patients, 2024
103
Average age 77
Drug cost, 2024
$11.2M
1,785 prescriptions
Company payments, 2025
$875
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jill N Burke was code 99215 (office e&m - established), 626 times for 102 patients. In total Jill N Burke billed 657 services in 5 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 626 | 102 | $96.29 | $60K |
By year: 2022 $68K for 671 services; 2023 $56K for 576 services; 2024 $62K for 657 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jill N Burke prescribed most often to Medicare patients was Lenalidomide, with 252 prescriptions and refills. In total Jill N Burke wrote 1,785 Medicare prescriptions that cost $11.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 252 | 252 | 32 | $3.4M |
| Acyclovir Generic | 232 | 593 | 69 | $4,065 |
| Revlimid Lenalidomide | 210 | 210 | 34 | $3.7M |
| Pomalyst Pomalidomide | 111 | 111 | 18 | $2.4M |
| Omeprazole Generic | 99 | 268 | 38 | $1,729 |
| Eliquis Apixaban | 62 | 92 | 12 | $52K |
| Celecoxib Generic | 55 | 58 | Under 11 | $1,670 |
| Ninlaro Ixazomib Citrate | 43 | 43 | Under 11 | $488K |
| Gabapentin Generic | 39 | 68 | Under 11 | $914 |
| Valacyclovir Valacyclovir Hcl | 36 | 75 | Under 11 | $2,208 |
| Azithromycin Generic | 29 | 29 | 27 | $65.96 |
| Lorazepam Generic | 25 | 26 | 12 | $96.94 |
| Venclexta Venetoclax | 25 | 25 | Under 11 | $372K |
| Dexamethasone Generic | 25 | 35 | 14 | $632 |
| Colestipol Hcl Generic | 24 | 56 | 11 | $1,819 |
Brand drugs: - claims; generic drugs: 1,257 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jill N Burke $875 ($875 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $875.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 3 | $875 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.